Latest options for treatment of bronchiolitis in infants
Bronchiolitis is the most frequent pathology associated with lower respiratory tract infection in newborns and young infants. The treatment of bronchiolitis is essentially supportive therapy for respiratory distress, hypoxia and dehydration. To date, no specific antiviral drug is used on a routine basis for the treatment of RSV infections. Currently, the only antiviral drug approved for the infection is ribavirin; however, its use is limited due to adverse side effects and the risks it poses to healthcare providers. Moreover, several drugs have been routinely administered for years in infants with acute RSV bronchiolitis, even if their efficacy is often not confirmed by clinical evidence, and studies on emerging antiviral drugs are still ongoing. In the present paper we review the recent literature about the drugs used during acute bronchiolitis and we summarize the main recommendations of national and international guidelines and the latest options for the treatment of bronchiolitis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Expert review of respiratory medicine - 10(2016), 4 vom: 03. Apr., Seite 453-461 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vandini, Silvia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bronchiolitis |
|---|
| Anmerkungen: |
Date Revised 20.11.2019 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1586/17476348.2016.1157473 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM257714200 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM257714200 | ||
| 003 | DE-627 | ||
| 005 | 20231224183429.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1586/17476348.2016.1157473 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0859.xml |
| 035 | |a (DE-627)NLM257714200 | ||
| 035 | |a (NLM)26901672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vandini, Silvia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Latest options for treatment of bronchiolitis in infants |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.11.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Bronchiolitis is the most frequent pathology associated with lower respiratory tract infection in newborns and young infants. The treatment of bronchiolitis is essentially supportive therapy for respiratory distress, hypoxia and dehydration. To date, no specific antiviral drug is used on a routine basis for the treatment of RSV infections. Currently, the only antiviral drug approved for the infection is ribavirin; however, its use is limited due to adverse side effects and the risks it poses to healthcare providers. Moreover, several drugs have been routinely administered for years in infants with acute RSV bronchiolitis, even if their efficacy is often not confirmed by clinical evidence, and studies on emerging antiviral drugs are still ongoing. In the present paper we review the recent literature about the drugs used during acute bronchiolitis and we summarize the main recommendations of national and international guidelines and the latest options for the treatment of bronchiolitis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bronchiolitis | |
| 650 | 4 | |a Bronchodilators | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a Epinephrine | |
| 650 | 4 | |a Hypertonic saline solution | |
| 650 | 4 | |a Infants | |
| 650 | 4 | |a Oxygen Therapy | |
| 650 | 4 | |a Respiratory Syncytial Virus | |
| 650 | 4 | |a Ribavirin | |
| 700 | 1 | |a Faldella, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Lanari, Marcello |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of respiratory medicine |d 2007 |g 10(2016), 4 vom: 03. Apr., Seite 453-461 |w (DE-627)NLM190765666 |x 1747-6356 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2016 |g number:4 |g day:03 |g month:04 |g pages:453-461 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1586/17476348.2016.1157473 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2016 |e 4 |b 03 |c 04 |h 453-461 | ||